AXSM — Axsome Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapNeutral

Annual balance sheet for Axsome Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	220	184	86.5	201	386
Net Total Accounts Receivable
Net Total Receivables	—	—	—	37.7	94.8
Total Inventory
Prepaid Expenses
Total Current Assets	220	184	86.5	246	504
Net Property, Plant And Equipment	0.031	1.79	0.944	1.14	7.62
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	221	186	87.8	331	588
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	24.5	23.4	23.1	96.6	139
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	41.8	72.3	72.2	222	397
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	179	114	15.6	110	191
Total Liabilities & Shareholders' Equity	221	186	87.8	331	588
Total Common Shares Outstanding